157 related articles for article (PubMed ID: 23111735)
1. A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells.
Zhang HH; Qi F; Zu XB; Cao YH; Miao JG; Xu L; Qi L
Med Sci Monit; 2012 Nov; 18(11):BR441-9. PubMed ID: 23111735
[TBL] [Abstract][Full Text] [Related]
2. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
[TBL] [Abstract][Full Text] [Related]
3. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
4. Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
Poyet C; Thomas L; Benoit TM; Delmo DA; Luberto L; Banzola I; Günthart MS; Sais G; Eberli D; Sulser T; Provenzano M
Oncotarget; 2017 Mar; 8(13):21871-21883. PubMed ID: 28423532
[TBL] [Abstract][Full Text] [Related]
5. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
6. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
7. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
8. Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis.
Taoka Y; Matsumoto K; Ohashi K; Minamida S; Hagiwara M; Nagi S; Saito T; Kodera Y; Iwamura M
Biomed Res; 2015; 36(4):253-61. PubMed ID: 26299484
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.
Barboro P; Rubagotti A; Orecchia P; Spina B; Truini M; Repaci E; Carmignani G; Romagnoli A; Introini C; Boccardo F; Carnemolla B; Balbi C
Cell Oncol; 2008; 30(1):13-26. PubMed ID: 18219107
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
12. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
Meng Q; Lei T; Zhang M; Zhao J; Zhao XH; Zhang M
J Cancer Res Clin Oncol; 2013 Mar; 139(3):509-19. PubMed ID: 23183654
[TBL] [Abstract][Full Text] [Related]
13. Does phosphorylation of cofilin affect the progression of human bladder cancer?
Chung H; Kim B; Jung SH; Won KJ; Jiang X; Lee CK; Lim SD; Yang SK; Song KH; Kim HS
BMC Cancer; 2013 Feb; 13():45. PubMed ID: 23374291
[TBL] [Abstract][Full Text] [Related]
14. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
15. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
16. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
Xue YJ; Lu Q; Sun ZX
Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
18. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.
Ou L; Guo Y; Luo C; Wu X; Zhao Y; Cai X
Cancer Genet Cytogenet; 2010 Jul; 200(2):110-9. PubMed ID: 20620593
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
20. Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.
Wang X; Zhang K; Sun L; Liu J; Lu H
Med Oncol; 2011 Dec; 28 Suppl 1():S413-22. PubMed ID: 21053100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]